Board Of Directors
Governance
BOD
Our distinguished members of the Board of Directors champion and support the Music Beats Cancer mission.
Mona S. Jhaveri, Ph.D.
Dr. Jhaveri is the Founder and Executive Director of Music Beats Cancer. Dr. Jhaveri holds a Doctorate in Biochemistry from the Bowman Gray School of Medicine of Wake Forest University. She trained as a post-doctoral fellow at the National Cancer Institute and at the Lombardi Cancer Center of Georgetown, where she was granted the SPORE Fellowship Award for Breast Cancer Research. Dr. Jhaveri specialized in intellectual property and technology transfer management while at the Ludwig Institute for Cancer Research.
In 2005, Dr. Jhaveri founded Foligo Therapeutics, Inc. to develop and commercialize a DNA-based therapeutic compound as a potential treatment for ovarian cancer. In 2010, Foligo’s poor funding position resulted in the shutdown of its R&D operation and abandonment of its lead compound in development. Dr. Jhaveri was inspired to launch Music Beats Cancer to help address the critical funding bottleneck that constrains cancer product development.
Reginald Swift
Reginald Swift, Ph.D is the Founder and CEO of Rubix LS, a visionary leader in healthcare innovation. With a background in mechanical engineering, he is renowned for pioneering the use of regenerative metals to target diseases like Multiple Sclerosis, ALS, PLS, PKAN, and rare infectious diseases. In addition to groundbreaking research, Reginald Swift is deeply committed to patient-centered care and actively promotes culturally competent clinical trials, ensuring that underserved patient communities have equitable access to cutting-edge treatments. His work is transforming the healthcare landscape, offering hope to individuals facing complex medical challenges, and making Rubix LS a leader in healthcare innovation and healthcare equity advocacy.
Josh Grubaugh
Josh is a Co-Founding Partner at WYO VC. He has over 20 years of experience as an investor, financer, operator, asset manager and business development executive with extensive experience in infrastructure, power, renewables and carbon strategy.
Josh previously led North American infrastructure investing for Hanwha Asset Management, launched Apple’s global decarbonization fund at Deutsche Asset Management, led Eastern US solar development and government contracting and supported Canadian solar development and module manufacturing at Recurrent Energy, and held various roles at InterGen with key accomplishments including helping manage the internal sell-side process for the sale of InterGen, helping lead a multi-billion dollar company debt restructuring and refinancing, and managing global strategy and planning for a power generation portfolio that at its peak was 22 gigawatts.
Josh also served on the R&D Advisory Board for the NSF CO-WY Climate Resilience Engine.